Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
1995-10-12
pubmed:abstractText
In the tumor-bearing host, T cells invariably fail to induce a clinically significant antitumor immune response. Although model systems support the existence of tumor peptide antigens, the molecular interactions critical for antigen presentation by the tumor cell remain unresolved. Here, we demonstrate that human follicular lymphoma cells are highly inefficient at presenting alloantigen despite their strong expression of major histocompatibility complex and low-to-intermediate expression of some adhesion and B7 costimulatory molecules. Activation of follicular lymphoma cells via CD40 induces or up-regulates both adhesion and B7 costimulatory molecules essential to repair this defect. More importantly, once primed, alloreactive T cells efficiently recognize unstimulated follicular lymphoma cells. Thus, correction of defective tumor immunity requires not only expression of major histocompatibility complex but also sufficient expression of multiple adhesion and costimulatory molecules.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-1335364, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-1847722, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-1944436, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-1972160, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-3118102, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-3315233, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-6756733, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7504293, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7506034, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7516669, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7525835, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7535594, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7537118, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7678351, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7681471, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7694363, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7694593, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7741031, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7826527, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7826529, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7836917, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7901318, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-7908301, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-8011285, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-8018207, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-8097319, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-8397772, http://linkedlifedata.com/resource/pubmed/commentcorrection/7545296-8469286
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
29
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8200-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.
pubmed:affiliation
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't